GLP-1 RA, Insulin Glargine Outperform DPP-4 Inhibitors and Sulfonyulreas in GRADE Study
Results of the GRADE Study suggest use of GLP-1 receptor agonists and insulin glargine U-100 outperformed sulfonylureas and DPP-4 inhibitors for glycemic control in people...

